Drugs for inflammation-driven diseases, such as rheumatoid arthritis, often aim to reduce the severity of the inflammatory response. Rauber et al. suggest an alternative strategy: promoting the resolution of inflammation. They found that IL-9 is needed for regulatory T (Treg) cells, which

中文翻译：

---

炎症性疾病：解决炎症的IL-9解决方案

用于类风湿性关节炎等炎症驱动疾病的药物通常旨在降低炎症反应的严重程度。Rauber等。建议另一种策略：促进炎症的消退。他们发现调节性T（Treg）细胞需要IL-9，